Abstract

Defective cognitive function is common in patients with diabetes, suggesting that insulin normally exerts anabolic actions in neuron, namely, diabetic encephalopathy. However, because insulin can cross-activate the insulin-like growth factor type 1 receptor (IGF-1R), which also functions in most of tissues, such as muscle and bone, it has been difficult to establish the direct (IGF-1-independent) actions of insulin in the pathogenesis of diabetic encephalopathy. To overcome this problem, we examined insulin signaling and action in primary PC-12 cells engineered for conditional disruption of the IGF-1 receptor (ΔIGF-1R). The results showed that the lower glucose metabolism and high expression of IGF-1R occurred in the brain of the DE rat model. The results also showed the defect of IGF-1R could significantly improve the ability of glucose consumption and enhance sensitivity to insulin-induced IR and Akt phosphorylation in PC12 cells. And meanwhile, IGF-1R allele gene knockout (IGF-1Rneo) mice treated with HFD/STZ had better cognitive abilities than those of wild mice. Those results indicate that insulin exerts direct anabolic actions in neuron-like cells by activation of its cognate receptor and prove that IGF-1R plays an important role in the pathogenesis of diabetic encephalopathy.

Highlights

  • The case reports are presented in the order of increasing severity of the neuropathological changes [1, 2]

  • We show that PC-12 cells lacking the insulin-like growth factor type 1 receptor (IGF-1R) are two to three times more sensitive to insulin than are cells expressing both receptors

  • It is concluded that insulin exerts direct anabolic actions in neuron-like cells by activation of its cognate receptor; the solid data provided in the study proves that IGF-1R plays an important role of in the pathogenesis of diabetic encephalopathy (DE)

Read more

Summary

Introduction

The case reports are presented in the order of increasing severity of the neuropathological changes [1, 2]. The severe damage found on histological examination of the brains from the patients justifies the term encephalopathy [3,4,5]. Diabetes and its treatment are associated with functional and structural disturbances in the brain [8,9,10]. Many existing publications focused on changes in cerebral function and structure that develop more insidiously [10]. These changes are referred to as diabetic encephalopathy (DE), a term that encompasses functional impairment of cognition, cerebral signal conduction, neurotransmission and synaptic plasticity, and underlying structural pathology associated with diabetes [11,12,13,14]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call